STAGE IIIB LUNG CANCER AJCC V8
Clinical trials for STAGE IIIB LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo takes on tough lung cancer
Disease control OngoingThis early-stage trial tests the safety and best dose of a new drug called minnelide when given with the standard drug osimertinib for people with advanced non-small cell lung cancer that has an EGFR mutation. The study involves about 8 adults whose cancer has spread or cannot be…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 29, 2026 00:51 UTC
-
Heat vs. scalpel: new study tests which lung tumor treatment works best
Disease control OngoingThis study compares two treatments for lung tumors: microwave ablation (using heat to kill cancer cells) and surgical wedge resection (removing a small piece of lung). It includes 74 adults with non-small cell lung cancer, sarcoma, or colorectal cancer that has spread to the lung…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 00:51 UTC
-
New combo therapy shows promise for tough lung cancers
Disease control OngoingThis study tests two drugs—niraparib and dostarlimab—together in people with small cell lung cancer or other high-grade neuroendocrine cancers that have already been treated. Niraparib blocks a repair process in cancer cells, while dostarlimab helps the immune system attack them.…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 00:51 UTC
-
Nurse-Led program aims to ease fear in advanced cancer patients
Symptom relief OngoingThis study tests a nurse-led program designed to help people with advanced lung or gynecologic cancer cope with fears about their future. The program teaches practical ways to manage worry and unhelpful thoughts. Researchers want to see if the program is practical and helpful for…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC
-
New hope for cancer patients losing appetite: drug shows promise in early trial
Symptom relief OngoingThis study looks at whether a drug called anamorelin can help improve appetite and stop weight loss in people with advanced non-small cell lung cancer who have lost their appetite and weight. About 25 participants will take either the drug or a placebo daily and share their exper…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC